In conclusion, our results unveil USP9X as a potential diagnostic, prognostic and therapeutic tool for cholangiocarcinoma, which provides a novel approach for use in noninvasive screening of cholangiocarcinoma. Here, USP9X is linked to cholangiocarcinoma.